Table 2.

Results of included studies.

Author/Year	Pain Score	Functional Score	Complications
Min et al., 2013	Mean improvement in VAS steroid group: 0.9	UCLA shoulder rating scale significantly better for NSAID group at 4 wks (p 0.03)	N-1 steroid group: vasovagal
	Mean improvement in VAS NSAID group: 1.83 (p 0.23)	Significantly greater active abduction in NSAID group at 4 wks (p 0.03)
Shakeel et al., 2012	Not Applicable	No significant difference at 3 mths (p 0.21)	N-10 steroid group
			Injection site pain (1), recurrence (9)
			N-8 NSAID group
			Injection site pain (2), swelling (3), stiffness (2), recurrence (1)
Bellamy et al., 2016	Mean improvement in VAS steroid group: 1.6 (p 0.003)	Mean WOMAC score for both ketorolac and corticosteroid increased from baseline at 2 weeks, 4 points (p 0.003) and 15 points (p 0.003), respectively	Not Applicable
	Mean improvement in VAS NSAID group: 1.7 (p 0.003)
Aldrete et al., 2003	Mean improvement in VAS Steroid group: 1.34 (p < 0.05)	Not applicable	There were no instances of apparent dual puncture or high sensory or motor block noted, nor were there any other untoward effects typical of NSAID therapy such as rash, epigastric discomfort, or bruising.
	Mean improvement in VAS NSAID (Indomethacin 1 mg) group: 1.16 (p < 0.05)
	Mean improvement in VAS NSAID group (Indomethacin 2 mg): 1.21 (p < 0.05)